Gameto
Gameto, Inc.
Gameto, Inc. is a clinical-stage biotechnology company developing novel therapies for women's reproductive health by leveraging cellular engineering. The company's primary focus is on making In Vitro Fertilization (IVF) and egg freezing shorter and safer by maturing eggs outside of the body, which significantly reduces the need for extensive hormonal injections.
Products & Team
Fertilo
Fertilo is a therapeutic solution derived from induced pluripotent stem cells (iPSCs) that contains engineered ovarian support cells. It is designed to mature a patient's eggs outside of the body (in vitro maturation), recreating the natural process in a laboratory setting.
Fertilo addresses the significant physical, emotional, and time-related burdens associated with conventional IVF and egg freezing by offering a shorter, safer, and more comfortable patient experience.
Patients currently face long and physically demanding hormone injection regimens, which can last 10-14 days and carry associated health risks and discomfort. Gameto's technology aims to alleviate these issues.